No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Australia
-
Calcium Channel Blockers / therapeutic use
-
Cardiovascular Diseases / drug therapy*
-
Cardiovascular Diseases / prevention & control*
-
Disease Management
-
Diuretics / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
National Health Programs / organization & administration*
-
Practice Guidelines as Topic*
-
Preventive Health Services / standards*
-
Primary Health Care / standards*
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Calcium Channel Blockers
-
Diuretics
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors